Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
71.5M
-
Shares change
-
+24.4M
-
Total reported value, excl. options
-
$151M
-
Value change
-
+$51.4M
-
Put/Call ratio
-
0.26
-
Number of buys
-
69
-
Number of sells
-
-20
-
Price
-
$2.11
Significant Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q4 2017
114 filings reported holding IDRA - IDERA PHARMACEUTICALS INC - COM NEW as of Q4 2017.
IDERA PHARMACEUTICALS INC - COM NEW (IDRA) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.5M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (18.3M shares), BlackRock Inc. (9.01M shares), Vanguard Group Inc (6.61M shares), MILLENNIUM MANAGEMENT LLC (3.85M shares), NATIXIS (3.44M shares), FMR LLC (3.27M shares), JPMORGAN CHASE & CO (3.27M shares), Bain Capital Public Equity Management, LLC (2.28M shares), STATE STREET CORP (2.08M shares), and Broadfin Capital, LLC (2.03M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.